Royal Perth Hospital Medical Research Foundation Incorporated
Concentration RiskGiving Philosophy
The foundation believes in supporting research across the full spectrum from early-stage seed funding to major translational projects that challenge existing paradigms. They emphasize translating innovative ideas into healthcare innovations with direct relevance to the WA public health system and measurable impact on patient outcomes. Their approach includes leveraging matched co-funding partnerships (such as with the WA Future Health Research and Innovation Fund) to maximize research investment.
Tips for Applicants
Applications should clearly demonstrate how research will translate into practical improvements for WA patients and the WA health system. Multi-disciplinary teams are valued. The foundation appreciates projects that challenge existing paradigms and has shown willingness to fund innovative approaches like AI/machine learning, stem cell therapy, and CAR T-cell development. Seed funding applicants should articulate how early investment could lead to larger evidence-based outcomes. For major grants, leverage partnerships and co-funding opportunities where possible.
Programs & Opportunities (3)
This grant supports early-stage medical research to bridge critical knowledge gaps and deliver real-world impact for patients in Western Australia and beyond.
Supports early-stage research to bridge critical knowledge gaps and enable pilot studies that can mature into larger evidence-based projects. The 2018 seed grant for MINOCA heart research demonstrates long-term impact potential.
These grants support mid-career and senior researchers who are translating their ideas into healthcare innovations that could lead to a significant impact on the health and wellbeing of the community, focusing on improving Western Australian patient outcomes.
Notable Grants
- $1,199,901 to A/Prof Agnes Yong for personalised BCMA-CAR T-cell therapy for myeloma patients (2024)
- $1,179,424 to Prof Graham Hillis for AI/machine learning to predict cardiovascular complications after surgery (2024)
- $1,147,285 to A/Prof Hun Chuah for Immuno-flowFISH pathway to detect and prevent leukaemia (2024)
- Seed funding grant in 2018 for MINOCA cardiac MRI research that led to international publication and changed clinical practice for heart attack diagnosis
Financial History (7 years)
| Year | Revenue | Expenses | Assets | Surplus |
|---|---|---|---|---|
| 2023 | $6.3M | $4.8M | $83.1M | $4.1M |
| 2022 | $9.4M | $9.7M | $77.6M | $1.2M |
| 2021 | $13.2M | $4.6M | $75.1M | $8.7M |
| 2020 | $5.4M | $10.6M | $66.5M | $-5,223,856 |
| 2019 | $6.8M | $5.1M | $71.3M | $1.6M |
| 2018 | $6.7M | $6.5M | $75.9M | $735K |
| 2017 | $5.1M | $5.2M | $74.3M | $1.5M |
Community Evidence
External EvidenceIdentity
- GS ID
- AU-ABN-62314475885
- ABN
- 62314475885
- Sector
- health
- Financial Year
- 2023
Focus Areas
Board & Leadership (11)
- board member
- board member
- board member
- board member
- board member
- ceo
- chair
- chair
- chair
- trustee
- trustee
Financials
- Revenue
- $6.3M
- Assets
- $83.1M
Method
- Match Confidence
- registry
- Cross-references
- 2 datasets
- Match Key
- ABN
- Relationships
- 31
Matched by Australian Business Number (ABN) — high confidence. This entity was found across multiple government datasets using the same ABN.
Data Sources
JusticeHub
External LinkThis entity is also tracked in JusticeHub with 0 interventions and 0 evidence records.
External ecosystem profile linked from GrantScope for additional context. JusticeHub content is maintained separately.
View on JusticeHubLocation Intelligence
- Postcode
- 6000
- Locality
- CITY DELIVERY CENTRE
- Remoteness
- Major Cities of Australia
- SEIFA Disadvantage
- Decile 8/10
- LGA
- Vincent
- SA2 Region
- Perth (West) - Northbridge
- Entities in Area
- 1,856